NIH Guide: Weekly Index for September 18, 2020

Funding Opportunities

• NIAID Research Education Program (R25 Clinical Trial Not Allowed)
  (PAR-20-289)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): December 7, 2020; May 25, 2021; and May 25, 2022
• Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03 Clinical Trial Not Allowed)
  (PAR-20-290)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 16, 2020.
• Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)
  (PAR-20-291)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 16, 2020.
• Drug Development Collaboratory (UG3/UH3 Clinical Trial Required)
  (PAR-20-301)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): February 9, 2021; June 9, 2021; February 9, 2022; June 9, 2022; February 9, 2023; June 9, 2023
• Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
  (PAR-20-304)
  National Library of Medicine
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is February 5, 2021.
• Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed)
  (RFA-CA-20-043)
  National Cancer Institute
  Application Receipt Date(s): January 20, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
• Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)
  (RFA-CA-20-051)
  National Cancer Institute
  Office of Disease Prevention
  Application Receipt Date(s): March 15, 2021; January 18, 2022 No late applications will be accepted for this Funding Opportunity Announcement.
• HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Clinical Centers (U01 Clinical Trial Not Allowed)
  (RFA-HL-21-015)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): December 7, 2020
• HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed)
  (RFA-HL-21-016)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): December 7, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed)
  (RFA-MH-20-556)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): February 11, 2021; October 19, 2021, by 5:00 PM local time of applicant organization.
• HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
  (RFA-NS-21-010)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Complementary and Integrative Health
  Office of Research on Women's Health
  Application Receipt Date(s): November 18, 2020, March 24, 2021, July 14, 2021, October 15, 2021, February 15, 2022, June 15, 2022, by 5:00PM local time of applicant organization. Alltypes of non-AIDS applicationsallowed for this funding opportunity announcement are due on these dates.
• Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (UG3/UH3 Clinical Trial Required)
  (RFA-TR-20-031)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): November 12, 2020
• Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
  (RFA-TR-20-032)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): November 12, 2020